Skip to main content
Type at least 3 characters

2,955 articles

Original Research

Published on 26 Mar 2025

Therapeutic mucosal vaccination of herpes simplex virus type 2 infected guinea pigs with an adenovirus-based vaccine expressing the ribonucleotide reductase 2 and glycoprotein D induces local tissue-resident CD4+ and CD8+ TRM cells associated with protection against recurrent genital herpes

in Vaccines and Molecular Therapeutics

  • Afshana Quadiri
  • Swayam Prakash
  • Hawa Vahed
  • Jimmy Medhat Tadros
  • Miyo Sun
  • Kathy K. Hormi-Carver
  • Swena Jignesh Patel
  • Lbachir BenMohamed
Frontiers in Immunology
doi 10.3389/fimmu.2025.1568258
  • 9,820 views

Original Research

Published on 20 Mar 2025

Evaluation of safety, immunogenicity, and efficacy of inactivated reverse-genetics-based H5N8 highly pathogenic avian influenza virus vaccine with various adjuvants via parenteral and mucosal routes in chickens

in Vaccines and Molecular Therapeutics

  • Kairat Tabynov
  • Aidana Kuanyshbek
  • Leila Yelchibayeva
  • Kuantay Zharmambet
  • Zauresh Zhumadilova
  • Gleb Fomin
  • Nikolai Petrovsky
  • Olaitan C. Shekoni
  • Gourapura J. Renukaradhya
  • Kaissar Tabynov
Frontiers in Immunology
doi 10.3389/fimmu.2025.1539492
  • 4,628 views
  • 1 citation

Clinical Trial

Published on 20 Mar 2025

Safety and immunogenicity of GamEvac-Combi, a heterologous rVSV- and rAd5-vectored Ebola vaccine: a randomized controlled multicenter clinical trial in the Republic of Guinea and Russia

in Vaccines and Molecular Therapeutics

  • Denis Y. Logunov
  • Inna V. Dolzhikova
  • Mamadou Y. Boiro
  • Anna V. Kovyrshina
  • Alina S. Dzharullaeva
  • Alina S. Erokhova
  • Daria M. Grousova
  • Amir I. Tukhvatulin
  • Fatima M. Izhaeva
  • Yana V. Simakova
Frontiers in Immunology
doi 10.3389/fimmu.2025.1487039
  • 2,145 views